This HTML5 document contains 128 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://dx.doi.org/10.1093/CID/
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37247235
rdf:type
wikibase:Item
schema:description
vetenskaplig artikel scientific article published on 13 August 2013 artigo científico wissenschaftlicher Artikel наукова стаття, опублікована в серпні 2013 bilimsel makale научни чланак مقالة علمية نشرت في 13 أغسطس 2013 article científic article scientifique vědecký článek videnskabelig artikel artículu científicu espublizáu en 2013 wetenschappelijk artikel articolo scientifico vedecký článok
p:P577
wds:Q37247235-14D0B230-9317-42F3-A9C6-15AEDCFCA4F4
wdt:P577
2013-08-13T00:00:00Z
p:P407
wds:Q37247235-9E68F78E-CE34-4D4B-8E68-1B6116071BB3
wdt:P407
wd:Q1860
p:P2860
wds:Q37247235-416E978D-E37E-4C7E-B10A-BEBB13C86C2F wds:Q37247235-4F537809-04EC-4B0E-96A7-D05290F678E2 wds:Q37247235-531E074A-7CD8-44C6-9F6C-4FED1B955B58 wds:Q37247235-632A71FD-58B6-48BE-9755-21454052EAFC wds:Q37247235-6935A6B3-B4EA-49FE-8916-AC8A4846AD19 wds:Q37247235-74670414-7AF7-4065-97EC-DE940BF452B6 wds:Q37247235-7563B489-ADB4-4FB7-B2E3-F937E3756A58 wds:Q37247235-00D2AF65-C360-4BA2-8EDB-DB5D37536128 wds:Q37247235-067BBB12-8CE0-4778-861D-834D659E6BD1 wds:Q37247235-37ABC5A7-0B73-4845-B025-F67A82F18194 wds:Q37247235-3F736620-AFC4-433A-B7CE-A17EDC1B96E8 wds:Q37247235-E93638D1-DF95-49CC-B67D-A14D14FDCA33 wds:Q37247235-EEA9B741-0262-4D12-BA4C-A0F193BE75D2 wds:Q37247235-EF042540-8BE4-497A-8BC5-43018AAA0BBE wds:Q37247235-F68689C7-E9D0-4055-97E1-180B43047B54 wds:Q37247235-859C3EED-6291-4AA1-AE89-92CEEC1B7ADD wds:Q37247235-85B156EF-E01D-4757-A07C-0185FC4B8FC9 wds:Q37247235-9F633EE8-470A-4F19-A265-41575B3EDB70 wds:Q37247235-9F96B43E-AE5C-4713-A8A7-F082B2F44D91 wds:Q37247235-AFF8D931-A4B8-4CC8-A325-4BB956D5542A wds:Q37247235-C7550470-26D5-4413-AF54-DF73AF1C2DE6 wds:Q37247235-C8271B70-891E-49A4-961A-0527081E3C25 wds:Q37247235-D7749471-8273-49A9-8516-2DDC983C5D8A wds:Q37247235-D7F7043F-EA20-4706-8C4D-7FE899312F2B wds:Q37247235-DF5A77D4-9F59-4584-A028-DFF405B61D7F wds:Q37247235-E03DE650-87EF-4532-BEC9-68DC70EDC93F
wdt:P2860
wd:Q27010898 wd:Q35719767 wd:Q39394695 wd:Q36623603 wd:Q36198650 wd:Q37641866 wd:Q44975155 wd:Q46755606 wd:Q37357149 wd:Q22242702 wd:Q44427873 wd:Q37454026 wd:Q44131254 wd:Q34119625 wd:Q33832012 wd:Q48738533 wd:Q37596221 wd:Q43653507 wd:Q36942349 wd:Q36393360 wd:Q37338133 wd:Q45975911 wd:Q46315882 wd:Q35000905 wd:Q37271202 wd:Q36839748
p:P2093
wds:Q37247235-8E377372-5C66-4E01-90D0-A1AAF1A032D0 wds:Q37247235-083F713C-B98F-477C-AF86-F1E7C82CDFF1 wds:Q37247235-3DD760B3-E22B-451D-8328-D2772C5383CB wds:Q37247235-325DBAE5-7956-4952-B7BC-127728F13918 wds:Q37247235-4387EFF6-8475-44F5-AD08-EDE5D70006B2 wds:Q37247235-80D1CA2D-137D-4ADA-BC7E-52EDD0FB308F wds:Q37247235-66DFD85C-FE6F-4BAD-B5F9-543BC4402D37
wdt:P2093
Sharon Riddler Michael P Dube Andrew R Zolopa Todd T Brown Douglas Kitch Richard Haubrich Philip M Grant
rdfs:label
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation
skos:prefLabel
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation
schema:name
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation
p:P50
wds:Q37247235-78C71A36-784E-4969-A949-062D05E5DF77 wds:Q37247235-54A5D15E-19B7-4DE2-8A76-071A7F17AB67 wds:Q37247235-80D98391-325A-47A0-B5BB-7A829F39E3C1 wds:Q37247235-E3FAB296-09DF-403B-99AA-3FDB5453B34F
wdt:P50
wd:Q42618377 wd:Q87874619 wd:Q57319976 wd:Q90899761
p:P1476
wds:Q37247235-A8EDD07B-0E2D-42AF-BE31-D6C3D42869FE
wdt:P1476
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation
p:P304
wds:Q37247235-22A67699-250E-42C1-A4DF-1E8734091FF1
wdt:P304
1483-1488
p:P31
wds:Q37247235-77179BCB-65E6-48DC-B787-F958F6244DF5
wdt:P31
wd:Q13442814
p:P921
wds:Q37247235-338048BE-9C18-4C90-A5A4-45FDF068C8D1
wdt:P921
wd:Q50430310
p:P698
wds:Q37247235-49A5CD80-D26E-4550-B33E-E0EACEC1B241
wdtn:P698
n12:23943825
wdt:P698
23943825
p:P1433
wds:Q37247235-059CF35C-9C7B-4F5F-963D-62571F330EB3
wdt:P1433
wd:Q5133764
p:P433
wds:Q37247235-E3885843-06F7-40ED-988E-BD779AFDD0E3
p:P478
wds:Q37247235-37D9B675-0DE7-49D3-A602-3E6F9B5DC8E7
wdt:P433
10
wdt:P478
57
p:P356
wds:Q37247235-416C0410-2BC0-4376-BD0C-016D6E0230B8
wdtn:P356
n10:CIT538
wdt:P356
10.1093/CID/CIT538
p:P5875
wds:Q37247235-AD722704-4697-427A-9B1B-DBF37DA1816E
wdt:P5875
255953251
p:P932
wds:Q37247235-6724720E-3AA3-4806-A656-0E0DF947668D
wdt:P932
3805172